Skip navigation

Toggle mobile navigation

News

A graphic of covid-19 viruses

Gilead Sciences Resubmits NDA to FDA for Lenacapavir

27 June 2022

A graphic is HIV viruses

Investigational Lenacapavir Receives Positive CHMP Opinion for investigational lenacapavir for the treatment of HIV-1 infection

24 June 2022

A nurse preps a patient arm for an injection

Combination anti-HIV antibody infusions suppress virus for prolonged period

01 June 2022

A patient has just received an injection in their arm

Second-Generation Long-Acting Injectables Significantly Improve Long-Term Severe Schizophrenia Outcomes

31 May 2022

A graphic of covid-19 viruses

ViiV Healthcare and MPP are actively negotiating voluntary licensing terms to help widen access to innovative HIV prevention measure

31 May 2022

A syringe is being filled from a vial.

MedAlliance's SELUTION SLR drug-eluting balloon (DEB) receives FDA investigational device exemption (IDE) approval

27 May 2022

A scientist is working in their lab

DelSiTech and Anticancer Bioscience Announce a Collaboration Agreement for the Development of Long-acting Therapies in Oncology

23 May 2022

A nurse preps a patient arm for an injection

FDA Lifts Clinical Hold on Long-Acting Lenacapavir

23 May 2022

A nurse preps a patient arm for an injection

Cali Biosciences Announces Successful Results in Phase IIb Study of Long-Acting Ropivacaine (CPL-01) for Non-Opioid Treatment of Post-Operative Pain

01 April 2022

Newer stories Older Stories